Harbor Investment Advisory, LLC Amicus Therapeutics, Inc. Transaction History

Harbor Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	BUY	$8.71 - $10.72 $5,696 - $7,010	654 Added 14.0%	5,324 $51,000
Q1 2021 Apr 16, 2021	BUY	$9.2 - $23.86 $18,639 - $48,340	2,026 Added 76.63%	4,670 $46,000
Q4 2020 Feb 04, 2021	BUY	$13.47 - $24.89 $30,051 - $55,529	2,231 Added 540.19%	2,644 $61,000
Q3 2020 Oct 23, 2020	BUY	$12.89 - $15.89 $5,323 - $6,562	413 New	413 $6,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.